AXSM
Axsome Therapeutics Inc.
Latest News for AXSM
An update from Axsome Therapeutics ( ($AXSM) ) is now available. On April 1, 2026, Axsome Therapeutics announced an asset purchase agreement to acq......
In a report released today, Yatin Suneja from Guggenheim maintained a Buy rating on Axsome Therapeutics, with a price target of $245.00. According ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Axsome Therapeutics (AXSM), Monte Rosa Therapeutics ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PolyPid (PYPD) and Axsome Therapeutics (AXSM) with b......
Growth stocks are companies whose sales and earnings are expected to grow faster than the market average, and investors buy them for their future p......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AXSM | $168.51 | 0% | 617.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Axsome Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW